Evidence map›Paper›PMID 26441657›Full record

ArticleFrontiers in pharmacology2015

5-HT6 receptor agonism facilitates emotional learning.

Marcela Pereira, Bruno J Martynhak, Roberto Andreatini, Per Svenningsson

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 41 citations in OpenAlex.

  1. Primary cilia and neural computation.Journal of biomedical science · 2026
    Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. WAY-208466, a 5-HTNeuroscience applied · 2024
    Article
  8. Impaired Aversive Memory Formation in GPR37L1KO Mice.International journal of molecular sciences · 2022
    Article
  9. Review
  10. Review
  11. 5-HT Receptors and the Development of New Antidepressants.International journal of molecular sciences · 2021
    Review
  12. Review
  13. Article
  14. Review
  15. Serotonin 5-HTCNS drugs · 2017
    Review
  16. The serotonergic system and cognitive function.Translational neuroscience · 2016
    Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Marcela PereiraSection of Translational Neuropharmacology, Department of Clinical Neuroscience, Center of Molecular Medicine, Karolinska Institute Stockholm, Sweden.
Bruno J MartynhakSection of Translational Neuropharmacology, Department of Clinical Neuroscience, Center of Molecular Medicine, Karolinska Institute Stockholm, Sweden.
Roberto AndreatiniDepartment of Pharmacology, Federal University of Paraná Curitiba, Brazil.
Per SvenningssonSection of Translational Neuropharmacology, Department of Clinical Neuroscience, Center of Molecular Medicine, Karolinska Institute Stockholm, Sweden.
Karolinska Institutet · SEUniversidade Federal do Paraná · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Serotonin (5-HT) and its receptors play crucial roles in various aspects of mood and cognitive functions. However, the role of specific 5-HT receptors in these processes remains to be better understood. Here, we examined the effects of the selective and potent 5-HT6 agonist (WAY208466) on mood, anxiety and emotional learning in mice. Male C57Bl/6J mice were therefore tested in the forced swim test (FST), elevated plus-maze (EPM), and passive avoidance tests (PA), respectively. In a dose-response experiment, mice were treated intraperitoneally with WAY208466 at 3, 9, or 27 mg/kg and examined in an open field arena open field test (OFT) followed by the FST. 9 mg/kg of WAY208466 reduced immobility in the FST, without impairing the locomotion. Thus, the dose of 9 mg/kg was subsequently used for tests of anxiety and emotional learning. There was no significant effect of WAY208466 in the EPM. In the PA, mice were trained 30 min before the treatment with saline or WAY208466. Two separate sets of animals were used for short term memory (tested 1 h post-training) or long term memory (tested 24 h post-training). WAY208466 improved both short and long term memories, evaluated by the latency to enter the dark compartment, in the PA. The WAY208466-treated animals also showed more grooming and rearing in the light compartment. To better understand the molecular mechanisms and brain regions involved in the facilitation of emotional learning by WAY208466, we studied its effects on signal transduction and immediate early gene expression. WAY208466 increased the levels of phospho-Ser(845)-GluA1 and phospho-Ser(217/221)-MEK in the caudate-putamen. Levels of phospho-Thr(202/204)-Erk1/2 and the ratio mature BDNF/proBDNF were increased in the hippocampus. Moreover, WAY208466 increased c-fos in the hippocampus and Arc expression in both hippocampus and prefrontal cortex (PFC). The results indicate antidepressant efficacy and facilitation of emotional learning by 5-HT6 receptor agonism via mechanisms that promote neuronal plasticity in caudate putamen, hippocampus, and PFC.

Indexed as

5-HT6antidepressantc-fosforced swim testMAPKmemorypassive avoidance

Identifiers

PMID26441657
PMCPMC4584947
OpenAlexW1738850168

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.